Mesenteric fibromatosis, also known as intra-abdominal desmoid tumor, is a rare, benign but locally aggressive condition that affects the mesentery, which is a fold of tissue that attaches the intestines to the abdominal wall and holds them in place.
This condition is characterized by the growth of fibrous tissue in the mesentery, leading to the formation of a mass or tumor that can potentially encase surrounding organs and structures.
Despite being benign, mesenteric fibromatosis can behave aggressively by infiltrating nearby tissues, and it may cause complications due to its size and location.
It does not metastasize to distant organs, but its local invasiveness can lead to significant issues such as bowel obstruction, pain, and can interfere with normal bowel function.
Diagnosis of mesenteric fibromatosis is typically achieved through imaging studies, with CT and MRI scans providing detailed information about the size, location, and extent of the tumor.
These imaging techniques are part of the 'Torso' scan category, which can reveal the characteristic features of the tumor in the abdomen region.
Treatment options may include surgical resection, although complete removal can be challenging due to the tumor's tendency to adhere to or encase critical structures.
In some cases, non-surgical treatments such as anti-inflammatory medications or targeted therapies may be employed to manage the condition.
Due to its potential to recur even after treatment, ongoing monitoring is essential.